Literature DB >> 12235133

Phosphorylation of tyrosine 291 enhances the ability of WASp to stimulate actin polymerization and filopodium formation. Wiskott-Aldrich Syndrome protein.

Giles O C Cory1, Ritu Garg, Rainer Cramer, Anne J Ridley.   

Abstract

Wiskott-Aldrich Syndrome protein (WASp) is a key regulator of the Arp2/3 complex and the actin cytoskeleton in hematopoietic cells. WASp is capable of forming an auto-inhibited conformation, which can be disrupted by binding of Cdc42 and phosphatidylinositol 4,5-bisphosphate, leading to its activation. Stimulation of the collagen receptor on platelets and crosslinking the B-cell receptor induce tyrosine phosphorylation of WASp. Here we show that the Src family kinase Hck induces phosphorylation of WASp-Tyr(291) independently of Cdc42 and that this causes a shift in the mobility of WASp upon SDS-PAGE. A phospho-mimicking mutant, WASp-Y291E, exhibited an enhanced ability to stimulate actin polymerization in a cell-free system and when microinjected into primary macrophages induced extensive filopodium formation with greater efficiency than wild-type WASp or a Y291F mutant. We propose that phosphorylation of Tyr(291) directly regulates WASp function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235133     DOI: 10.1074/jbc.M203346200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  Impaired cell adhesion, apoptosis, and signaling in WASP gene-disrupted Nalm-6 pre-B cells and recovery of cell adhesion using a transducible form of WASp.

Authors:  Rikiya Sato; Susumu Iiizumi; Eun-Sung Kim; Fumiko Honda; Sang-Kyou Lee; Noritaka Adachi; Hideki Koyama; Shuki Mizutani; Tomohiro Morio
Journal:  Int J Hematol       Date:  2012-02-05       Impact factor: 2.490

2.  Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia.

Authors:  Matthew Oser; Christopher C Mader; Hava Gil-Henn; Marco Magalhaes; Jose Javier Bravo-Cordero; Anthony J Koleske; John Condeelis
Journal:  J Cell Sci       Date:  2010-11-01       Impact factor: 5.285

3.  Paxillin phosphorylation controls invadopodia/podosomes spatiotemporal organization.

Authors:  Cédric Badowski; Géraldine Pawlak; Alexei Grichine; Anne Chabadel; Christiane Oddou; Pierre Jurdic; Martin Pfaff; Corinne Albigès-Rizo; Marc R Block
Journal:  Mol Biol Cell       Date:  2007-11-28       Impact factor: 4.138

4.  Activating mutations of N-WASP alter Shigella pathogenesis.

Authors:  David A Adamovich; Fumihiko Nakamura; Austen Worth; Siobhan Burns; Adrian J Thrasher; John H Hartwig; Scott B Snapper
Journal:  Biochem Biophys Res Commun       Date:  2009-04-18       Impact factor: 3.575

Review 5.  The pivotal position of the actin cytoskeleton in the initiation and regulation of B cell receptor activation.

Authors:  Wenxia Song; Chaohong Liu; Arpita Upadhyaya
Journal:  Biochim Biophys Acta       Date:  2013-07-23

Review 6.  The diverse functions of Src family kinases in macrophages.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Front Biosci       Date:  2008-05-01

Review 7.  Natural killer cell cytotoxicity: how do they pull the trigger?

Authors:  Nicola J Topham; Eric W Hewitt
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

8.  The mechanism of CSF-1-induced Wiskott-Aldrich syndrome protein activation in vivo: a role for phosphatidylinositol 3-kinase and Cdc42.

Authors:  Michael Cammer; Jean-Claude Gevrey; Mike Lorenz; Athanassios Dovas; John Condeelis; Dianne Cox
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

Review 9.  Regulation of tyrosine phosphorylation in macrophage phagocytosis and chemotaxis.

Authors:  Haein Park; Dan Ishihara; Dianne Cox
Journal:  Arch Biochem Biophys       Date:  2011-02-26       Impact factor: 4.013

10.  MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta.

Authors:  Jacquelyn A Woodings; Stewart J Sharp; Laura M Machesky
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.